Completed

Isoflurane's Effects on Mood, Psychomotor Skills and Cold-Water Immersion Pain

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
Study Aim

This phase 2 study aims to evaluate how inhaled isoflurane affects your pain response when your arm is immersed in ice cold water, using nitrous oxide as a comparison to confirm the sensitivity of the pain test.

What is being tested

Using 40% Nitrous Oxide for Pain Control

+ Sham Comparator in Oxygen

+ Using 40% Nitrous Oxide for Pain Control

DrugOther
Who is being recruted

Narcotic-Related Disorders+2

+ Mental Disorders

+ Chemically-Induced Disorders

From 21 to 34 Years
See all eligibility criteria
How is the trial designed

Treatment Study

Placebo-ControlledPhase 2
Interventional
Study Start: January 1995
See protocol details

Summary

Principal SponsorUniversity of Chicago
Last updated: May 28, 2015
Sourced from a government-validated database.Claim as a partner

Study start date: January 1, 1995

Actual date on which the first participant was enrolled.

This study focuses on understanding the effects of nitrous oxide, a gas often used for pain relief and sedation, on non-drug abusers. It also explores the impact of isoflurane, another anesthetic agent, on pain response. The research aims to test if isoflurane at subanesthetic concentrations can reduce pain caused by cold-water immersion in healthy individuals. This study is important as it may help improve our understanding of how these drugs affect mood, psychomotor skills, and pain perception, potentially leading to better pain management strategies.

NCT00000254
Principal SponsorUniversity of Chicago
Last updated: May 28, 2015
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

10 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Treatment Study

These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.



Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Male

Biological sex of participants that are eligible to enroll.

From 21 to 34 Years

Range of ages for which participants are eligible to join.

Healthy volunteers allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Narcotic-Related DisordersMental DisordersChemically-Induced DisordersOpioid-Related DisordersSubstance-Related Disorders

Criteria

Please contact site for information.

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

4 intervention groups are designated in this study

25% chance of being blinded to the placebo group

Treatment Groups

Group I

Sham

Group II

Active Comparator

Group III

Active Comparator

Group IV

Active Comparator

Study Objectives

Primary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

University of Chicago, Anesthesia & Critical Care

Chicago, United StatesOpen University of Chicago, Anesthesia & Critical Care in Google Maps
CompletedOne Study Center